Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Chief Medical Officer and member, Pharmacovigilance Risk Assessment Committee (PRAC) at Danish Medicines Agency
During 12 years (July 1986 – May 1998) she worked as a physician at university hospitals in the Copenhagen area (Hvidovre, Frederiksberg, Herlev, Roskilde), primarily in departments specialized in internal medicine, nephrology and endocrinology. In 1995 she became specialist in internal medicine. Her clinical experience also covers haematology, cardiology and infectious diseases. Her research activities and publications were primarily within the areas of haematology, immunology, nephrology and endocrinology.
She joined the Danish Medicines Agency in June 1998, initially as senior medical officer; in 2002 appointed chief medical officer (current position). She was member of the EU Pharmacovigilance Working Party from June 1998 until July 2012. Since July 2012 she has been member of the Pharmacovigilance Risk Assessment Committee (PRAC). Her regulatory experience comprises all aspects of pharmacovigilance, including scientific evaluation of drug safety issues, development of risk management strategies, policies and guidelines, provision of scientific advice to the pharmaceutical industry, and communication to health care professionals and the public. Author of several international publications on various aspects of pharmacovigilance.